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Alcohol, tobacco and breast cancer – collaborative reanalysis of
individual data from 53 epidemiological studies, including 58 515
women with breast cancer and 95 067 women without the
disease
Collaborative Group on Hormonal Factors in Breast Cancer*,1
1Secretariat, Cancer Research UK Epidemiology Unit, Gibson Building, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
Alcohol and tobacco consumption are closely correlated and published results on their association with breast cancer have not
always allowed adequately for confounding between these exposures. Over 80% of the relevant information worldwide on
alcohol and tobacco consumption and breast cancer were collated, checked and analysed centrally. Analyses included 58 515
women with invasive breast cancer and 95 067 controls from 53 studies. Relative risks of breast cancer were estimated, after
stratifying by study, age, parity and, where appropriate, women’s age when their first child was born and consumption of alcohol
and tobacco. The average consumption of alcohol reported by controls from developed countries was 6.0 g per day, i.e. about
half a unit/drink of alcohol per day, and was greater in ever-smokers than never-smokers, (8.4 g per day and 5.0 g per day,
respectively). Compared with women who reported drinking no alcohol, the relative risk of breast cancer was 1.32 (1.19 – 1.45,
P50.00001) for an intake of 35 – 44 g per day alcohol, and 1.46 (1.33 – 1.61, P50.00001) for 545 g per day alcohol. The
relative risk of breast cancer increased by 7.1% (95% CI 5.5 – 8.7%; P50.00001) for each additional 10 g per day intake of
alcohol, i.e. for each extra unit or drink of alcohol consumed on a daily basis. This increase was the same in ever-smokers and
never-smokers (7.1% per 10 g per day, P50.00001, in each group). By contrast, the relationship between smoking and breast
cancer was substantially confounded by the effect of alcohol. When analyses were restricted to 22 255 women with breast
cancer and 40 832 controls who reported drinking no alcohol, smoking was not associated with breast cancer (compared to
never-smokers, relative risk for ever-smokers=1.03, 95% CI 0.98 – 1.07, and for current smokers=0.99, 0.92 – 1.05). The results
for alcohol and for tobacco did not vary substantially across studies, study designs, or according to 15 personal characteristics of
the women; nor were the findings materially confounded by any of these factors. If the observed relationship for alcohol is
causal, these results suggest that about 4% of the breast cancers in developed countries are attributable to alcohol. In developing
countries, where alcohol consumption among controls averaged only 0.4 g per day, alcohol would have a negligible effect on the
incidence of breast cancer. In conclusion, smoking has little or no independent effect on the risk of developing breast cancer; the
effect of alcohol on breast cancer needs to be interpreted in the context of its beneficial effects, in moderation, on
cardiovascular disease and its harmful effects on cirrhosis and cancers of the mouth, larynx, oesophagus and liver.
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Many epidemiological studies have investigated the relationship
between breast cancer and the consumption of alcohol and/or tobac-
co. References to over 80 studies that have collected relevant data, as
well as to reviews of the subject, are given in Appendix II (www.
bjcancer.com). The published results from these studies have gener-
ally suggested that women who regularly consume alcohol may be at a
slightly increased risk of the disease, but the findings reported for
tobacco are inconsistent. Alcohol and tobacco consumption are
known to be associated one with another, and published results have
not always allowed adequately for possible confounding between
these exposures. Individual data from 65 epidemiological studies of
breast cancer 63 published1 – 63 and two unpublished in which infor-
mation on alcohol and/or tobacco consumption had been collected
contributed to this collaboration. These studies, some of which have
not published results for alcohol or tobacco, include over 80% of the
worldwide information on the topic (see Appendix II (www.bjcan-
cer.com)). The data from these studies were analysed, taking
careful account of the possible confounding between alcohol and
tobacco consumption, as well as confounding by other factors.
METHODS
Eligibility of studies and collection of data
Data from epidemiological studies of women with breast cancer
have been brought together by the Collaborative Group on
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Hormonal Factors in Breast Cancer to describe the relationship
between breast cancer and various reproductive, hormonal and
other factors.64,65 Case – control and cohort studies were eligible
for the collaboration if they included at least 100 women with inci-
dent invasive breast cancer and recorded information on
reproductive factors and on use of hormonal therapies. Cohort
studies were included using a nested case – control design, in which
four controls were selected at random, matched on follow-up to
the age of the case at diagnosis and, where appropriate, broad
geographical region. Data for individual women were collated
and analysed centrally so that analyses could be carried out using
as similar definitions across studies as was possible. Details sought
from principal investigators of each participating study included
data that had been collected on each woman’s reproductive history
and various other factors that may be relevant to the aetiology of
breast cancer, including the women’s consumption of alcohol and
tobacco.
Some investigators provided estimates of alcohol intake
reported by each woman expressed as gram (g) of alcohol
consumed per day or per week. Others provided information
on the reported number of alcoholic drinks consumed daily or
weekly. In such instances, the number of grams of alcohol
consumed per day, was estimated assuming that one alcoholic
drink contains 12 g alcohol in the USA and Italy,11 8 g in the
UK and 10 g elsewhere (Brewers’ Society, personal communica-
tion). No information was sought about alcohol consumption at
various ages or about the particular type of alcohol consumed.
Information was also sought on whether or not each woman
had ever smoked, and whether she was a current or past smoker.
Active smoking only was considered and no attention given to the
reported associations with environmental tobacco smoke,35,49 nor
was information sought on the age women were when smoking
started or stopped, or on the amount smoked. The methods of
identifying studies and of data checking, and correction, have
been described elsewhere.64,65
Statistical analysis and presentation of results
Statistical methods were similar to those used in previous reports
by this group.64 – 67 Data from different studies were combined
by means of the Mantel – Haenszel stratification technique, the
stratum-specific quantities calculated being the standard ‘observed
minus expected’ (O – E) numbers of women with breast cancer,
together with their variances and covariances. These values yield
both statistical descriptions (odds ratios, subsequently referred to
as relative risks) and statistical tests (P values). When only two
groups are being compared, relative risk estimates are obtained
from O – E values by the one-step method,66 as are their standard
errors (SE) and confidence intervals (CI). When more than two
groups are compared, variances are estimated by treating the rela-
tive risks as floating absolute risks (FARs).67 This approach yields
floated standard errors (FSE) and floated confidence intervals
(FCI). Presentation of the results in this way enables valid compar-
isons between any two exposure groups, even if neither is the
baseline group. Any comparison between groups must take the
variation in each estimate into account by summing the variances
of the logarithms of the two FARs.
To obtain comparability between the women with breast cancer
and similar women without breast cancer, all analyses were routi-
nely stratified by study, and centre within study; by age (in single
years from 16 to 64, 65 to 69, 70 to 74, etc., up to 85 to 89); by
parity and, where appropriate, age when the first child was born
(nulliparous women were assigned to a separate stratum and
parous women were cross-classified according to parity (1 – 2, 3 –
4, 5 – 6, 7+) and age at first birth (520, 20 – 24, 25 – 29, 30+)).
Where appropriate analyses relating to alcohol consumption were
stratified by smoking history (ever/never) and analyses relating to
tobacco consumption were stratified by alcohol consumption (0,
55, 5 – 14, 15 – 24, 25 – 34, 35 – 44, 545 g per day). In order to
summarise the relationship between alcohol consumption and
breast cancer risk, a linear trend in the log relative risk of breast
cancer was fitted across increasing categories of consumption. In
estimating such trends, the median consumption within a given
category was taken to be the level of alcohol consumption for that
category.
In general, results in the text are presented as relative risks and
their appropriate SE or FSEs. Where results are presented in the
form of plots, relative risks and their corresponding CIs/FCIs are
represented by squares and lines, respectively. The position of the
square indicates the value of the relative risk and its area is inver-
sely proportional to the variance of the logarithm of the relative
risk, thereby providing an indication of the amount of statistical
information available for that particular estimate. Owing to the
large number of relative risk estimates calculated, results are given
with their appropriate 99% CIs/FCIs; and 95% CIs/FCIs are used
only to summarise the main findings.
The absolute risk of breast cancer associated with various levels
of alcohol consumption was estimated for women in developed
countries, by applying the dose-response estimates obtained here
to age-specific incidence rates for breast cancer in developed coun-
tries around 199064,65 assuming that an intake of 10 g per day is
roughly equivalent to one unit or drink of alcohol per day. The
cumulative incidence of breast cancer up to age 80 years was calcu-
lated from the age-specific findings.
RESULTS
The 65 studies that contributed individual data on alcohol and/
or tobacco consumption and other factors relevant to breast
cancer included a total of 66 426 women with invasive breast
cancer (cases) and 126 953 women without breast cancer controls
from 63 published1 – 63 and two unpublished studies. Information
on both alcohol and tobacco had been collected in 53 of these
studies, that included a total of 58 515 cases and 95 067 controls
from 51 published1 – 51 and two unpublished studies. Unless
otherwise specified, analyses presented here are restricted to data
from these 53 studies. This enables women to be cross-classified
by both their alcohol and tobacco consumption, thus permitting
adequate examination of possible confounding between the two
exposures.
Among women with breast cancer in the 53 studies included in
the main analyses, the median year of diagnosis was 1988 and the
average age at diagnosis was 52.1 years. All but five of the 53
studies5,9,21,41,48 were conducted in developed countries. Among
controls, alcohol consumption was substantially greater in women
from developed than developing countries (average alcohol intakes
of 6.0 g per day and 0.4 g per day, respectively). The proportion of
controls from developed countries who reported drinking no alco-
hol was 40%, and a further 28% reported consuming 55 g per
day, i.e. less than half a unit/drink of alcohol per day (Table 1).
Only about 1% of the controls from developed countries reported
drinking 35 – 44 g per day alcohol, i.e. about four units or drinks
daily, and a similar proportion reported drinking 545 g per day.
Overall about half the women in developed countries reported
that they had ever smoked, but smoking habits varied consider-
ably according to alcohol intake, both for cases and controls
(Table 1). Among controls from developed countries who
reported drinking no alcohol, 37% had ever smoked, and the
proportion of ever-smokers increased with increasing intake of
alcohol, rising to 73% for controls who reported drinking
545 g per day alcohol (Table 1). The average alcohol consump-
tion reported by ever-smokers from developed countries was
greater than that reported by never-smokers (8.4 g per day vs
5.0 g per day).
E
p
id
em
io
lo
gy
Alcohol, tobacco and breast cancer
Collaborative Group on Hormonal Factors in Breast Cancer
1235
ª 2002 Cancer Research UK British Journal of Cancer (2002) 87(11), 1234 – 1245
Because alcohol and tobacco consumption are so closely asso-
ciated, analyses of their effects were initially carried out
separately for never-smokers and ever-smokers (in the case of alco-
hol) and for drinkers and non-drinkers (in the case of tobacco).
Breast cancer in relation to alcohol consumption
Table 2 shows the relative risks and corresponding standard errors
for breast cancer according to women’s reported daily intake of
alcohol for never-smokers and ever-smokers. In each group the
relative risk of breast cancer increased significantly with increasing
intake of alcohol, increasing by the same amount, 7.1%, for each
additional 10 g per day intake of alcohol (P50.00001 in each
group). The trends associated with increasing levels of alcohol
intake in never-smokers and ever-smokers did not differ signifi-
cantly from each other (w21 for heterogeneity=0.002; P=1.0).
Therefore subsequent analyses concerning alcohol consumption
include both never-smokers and ever-smokers, and the data are
stratified by smoking history as well as by study, age, parity and
age at first birth.
When the data in smokers and non-smokers were combined the
relative risk of breast cancer increased with alcohol intake, increas-
ing by 7.1% (SE 0.8%; P50.00001) for each additional 10 g per
day intake of alcohol, i.e. for each extra unit/drink of alcohol
consumed on a daily basis (Figure 1). Compared to women who
drank no alcohol the relative risk was 1.32 (0.059, P50.00001)
for women whose reported alcohol consumption was 35 – 44 g
per day and 1.46 (0.060, P50.00001) for a consumption of
545 g per day, where the average consumption was 57 g per day.
The study-specific results are summarised in Figure 2, grouped
according to study design. Studies which contributed the smallest
amounts of statistical information, were grouped together as
‘other’ in each of these categories. There was no strong evidence
to suggest that the results varied substantially across studies
(w252=60.7; P=0.3) or according to study design (w
2
2 for heteroge-
neity=1.5; P=0.5). In the one study52 which contributed data on
alcohol, but not smoking, the estimated increase in the relative
risk of breast cancer per additional 10 g per day intake was
13.8% (SE 10.5%). Because of the large standard error, the esti-
mated increase in relative risk in this study does not differ
significantly from results for all other studies combined
(w21=0.4, P=0.5).
The effect of adjusting for 11 other potential confounding
factors (race, education, family history of breast cancer, age at
menarche, height, weight, body mass index, breastfeeding, use of
hormonal preparations, and age at and type of menopause) on
the relationship in Figure 1 is shown in Table 3. Additional adjust-
ment for each of these factors in turn did not materially alter the
magnitude of the increase in the relative risk of breast cancer asso-
ciated with increasing levels of alcohol intake, suggesting that the
associations in Figure 1 are not much confounded by any of them.
Breast cancer in relation to tobacco consumption
Among the 22 255 cases and 40 832 controls who reported drinking
no alcohol, the risk of breast cancer in ever-smokers did not differ
significantly from that in never-smokers (relative risk for ever vs
never-smokers=1.03, SE 0.023; NS). However, among women
who reported drinking alcohol, the findings for smoking were diffi-
cult to disentangle from the effects of the alcohol itself. When ever-
smokers were compared to never-smokers the relative risk for
breast cancer was 1.09 (0.018) before stratification by the amount
of alcohol consumed, and declined to 1.05 (0.020) after stratifica-
tion. The corresponding w21 value declined by three-quarters from
23.4 to 6.4. Since alcohol consumption is known to be unreliably
measured,68 and stratification for such a poorly measured variable
reduced the w2 value by three-quarters, stratification by true alco-
hol intake would be expected to reduce the w2 value by even
more.69 Since it is not possible to eliminate residual confounding
among drinkers, results concerning tobacco consumption are
restricted to women who reported drinking no alcohol at all, where
such confounding should be minimised.
The study-specific relative risks for breast cancer in ever-smokers
compared to never-smokers are shown in Figure 3, for women who
reported drinking no alcohol. There was no marked variation in the
relative risk of breast cancer across studies (w252=58.0, P=0.3) or
study design (w22=6.1, P=0.05). Information on current and past
smoking was available for all but five studies.2,23,28 (and two unpub-
lished). Among ever-smokers in the remaining 48 studies 54% were
current smokers and 46% were past smokers. Compared to never-
smokers the relative risk of breast cancer was 0.99 (SE 0.03) for
current smokers (Appendix III (www.bjcancer.com)), and 1.07
(SE 0.03) for past smokers (Appendix IV (www.bjcancer.com)).
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Table 2 Relative riska of breast cancer in relation to reported intake of
alcohol, according to smoking history
g per day alcohol Never-smoker Ever-smoker All women
consumption relative riska relative riska relative riska
(median) (FSE) (FSE) (FSE)
0 (0) 1.00 (0.015) 1.00 (0.018) 1.00 (0.012)
55 (2) 1.01 (0.020) 1.01 (0.020) 1.01 (0.014)
5 – 14 (8) 1.01 (0.023) 1.05 (0.021) 1.03 (0.015)
15 – 24 (18) 1.19 (0.048) 1.09 (0.035) 1.13 (0.028)
25 – 34 (29) 1.22 (0.056) 1.19 (0.047) 1.21 (0.036)
35 – 44 (39) 1.18 (0.093) 1.40 (0.077) 1.32 (0.059)
545 (58) 1.49 (0.110) 1.46 (0.072) 1.46 (0.060)
Increase in the relative
risk of breast cancer
per 10 g per day (SE) 7.1% (1.3%) 7.1% (0.9%) 7.1% (0.8%)
aCalculated as floating absolute risk (FAR), with corresponding floated standard error
(FSE), and stratified by study, age, parity, age at first birth and, for ‘all women’, by
smoking history (see Methods).
Table 1 Reported alcohol and tobacco consumption among cases and controls in developed countries for whom information on both
factors was available
Alcohol consumption (g per day)
0 1 – 4 5 – 14 15 – 24 25 – 34 35 – 44 45+ Total
CASES
Number (%) 18331 (36) 13785 (27) 10238 (20) 3444 (6.8) 2522 (5.0) 954 (1.9) 1192 (2.4) 50466 (100)
Per cent that ever-smoked 39% 48% 58% 60% 56% 64% 70% 49%
CONTROLS
Number (%) 31872 (40) 22654 (28) 15484 (19) 5082 (6.3) 2727 (3.4) 1119 (1.4) 1067 (1.3) 80005 (100)
Per cent that ever-smoked 37% 46% 55% 62% 60% 66% 73% 46%
Alcohol, tobacco and breast cancer
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Among controls from developed countries a greater proportion
of ever-smokers than never-smokers had had a bilateral oophor-
ectomy (8.7% vs 7.6%) or a hysterectomy without bilateral
oophorectomy (13.3% vs 12.5%). The average age at bilateral
oophorectomy was 41.6 (SD 7.5) and 44.2 (SD 6.6), respectively
and the average age at hysterectomy was 38.6 (SD 9.3) and 40.0
(SD 9.9), respectively. Average age at natural menopause was also
slightly earlier in ever-smokers than in never smokers, at 48.3 (SD
4.8) and 49.3 (SD 4.7) years, respectively. The relative risk of
breast cancer in ever vs never-smokers was similar for women
who had had an oophorectomy, hysterectomy or natural meno-
pause (Table 4) and additional stratification by age at and type
of menopause did not materially alter the overall magnitude of
the relative risk (Table 3). Nor did additional stratification by
10 other potential confounding factors much alter the relative
risk.
Eleven studies53 – 63 that together included a total of 4781 cases
and 12 713 controls, contributed data to this collaboration on
tobacco consumption for each woman, but not on alcohol
consumption. The combined relative risk of breast cancer in
ever-smokers compared to never-smokers in these 11 studies was
1.05 (SE 0.05), but because of the potential for confounding by
alcohol the results from these studies have not been included in
the main analyses.
Consistency of the findings
The increase in the relative risk of breast cancer for each addi-
tional 10 g per day intake of alcohol consumption was
calculated separately for various subgroups of women, subdi-
vided according to 15 personal characteristics including their
age, childbearing pattern, race and familial patterns of breast
cancer. Overall there was no significant variation in the trend
associated with increasing intake of alcohol between categories
defined by any of the 15 factors examined (Figure 4: global test
for heterogeneity w215=18.0; P=0.3). Nor was there significant
variation in the relative risk of breast cancer associated with
having ever smoked across categories of the 15 characteristics
examined (Figure 4: global test for heterogeneity w215=17.9;
P=0.3).
Information on the extent of spread of the breast cancer was
available for about 60% of the study population. Both for
tumours localised to the breast and for tumours that had
spread beyond the breast, the risk of breast cancer increased
with increasing alcohol consumption (increase in relative risk
of breast cancer of 6.9% (1.3%) and 9.4% (1.5%), respectively,
per 10 g per day alcohol consumption: w21=3.3; P=0.07). There
was no significant difference in the extent of tumour spread
among the cases according to tobacco consumption (w21=3.0,
P=0.08).
Cumulative incidence of breast cancer
Around 1990 the cumulative incidence of breast cancer up to age
80 years was between about eight and 10 per 100 women in devel-
oped countries.64,65,70 The average consumption of alcohol by
controls studied here from developed countries was 6.0 g per
day. If the dose-response relationship described here is valid, it is
E
p
id
em
io
lo
gy
1.7
1.6
1.5
1.4
1.3
1.2
1.1
1.0
0.9
R
el
at
ive
 r
is
k 
(95
% 
FC
I)
0 (0) 10 (1) 20 (2) 30 (3) 40 (4) 50 (5) 60 (6)
Self-reported alcohol consumption, g per day (~ number drinks daily)
Figure 1 Relative risk of breast cancer in relation to reported intake of alcohol. Relative risks are calculated as floating absolute risk (FAR) and stratified by
study, age, parity, age at first birth and smoking.
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Figure 2 Details of and results from studies on the relation between alcohol consumption and breast cancer. Relative risks are stratified by age, parity, age
at first birth and smoking history.
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Figure 3 Details of and results on the relation between tobacco consumption and breast cancer in women who reported drinking no alcohol. Relative
risks are stratified by age, parity and age at first birth.
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estimated that about 4% of breast cancers in developed countries
are attributable to alcohol. The cumulative incidence of breast
cancer by age 80 years is estimated to increase from 8.8 per 100
women in non-drinkers to 9.4, 10.1, 10.8, 11.6, 12.4 and 13.3,
respectively, per 100 women consuming an average of 1, 2, 3, 4,
5 and 6 alcoholic drinks each day (see Figure 5). In developing
countries, where alcohol consumption is very low, averaging only
about 0.4 g per day, alcohol would make a negligible contribution
to the total number of cases of breast cancer.
DISCUSSION
There is potential for confounding between the possible effects of
alcohol and of tobacco on breast cancer, as drinking and smoking
are closely associated, one with another. Among controls from
developed countries, the proportion of ever-smokers rose from
37% in women who reported drinking no alcohol at all, to 73%
in women drinking 545 g per day alcohol, and alcohol consump-
tion was greater in ever-smokers than in never-smokers, averaging
8.4 and 5.0 g per day, respectively.
The relative risk of breast cancer was found to increase with
increasing intake of alcohol, both in never-smokers and in ever-
smokers, and the magnitude of the increase was the same in each
group (an increase of 7.1% in the relative risk of breast cancer for
each additional 10 g per day alcohol; 95% CI 5.5 – 8.7%
P50.00001 overall). The observed association between breast
cancer and alcohol consumption is therefore unlikely to be an
indirect effect of tobacco.
Conversely, the relationship between smoking and breast
cancer was found to be confounded by alcohol. Among women
who drank no alcohol, ever-smokers and current smokers were
not at an increased risk of breast cancer compared to never-
smokers. Among women who drank alcohol, however, adjust-
ment of the relative risk of breast cancer by the amount of
alcohol consumed had a substantial effect on the results and,
since it is not possible to measure alcohol intake reliably and
thus eliminate residual confounding due to alcohol, we chose
to base our assessment of the effect of tobacco on breast cancer
on the 22 255 cases and 40 832 controls recorded as drinking no
alcohol at all. In this large group of women the results suggest
that smoking has little or no independent effect on the risk of
developing breast cancer.
The association between breast cancer and alcohol or tobacco
consumption does not appear to be materially confounded by
the effects of other factors. Potential confounding by age, study,
parity, age at first birth and tobacco consumption were minimised
by stratification. Ever-smokers had their natural menopause about
1 year earlier, on average than never-smokers and were also more
likely to have had a bilateral oophorectomy or hysterectomy, but
adjustment for type of and age at menopause had little effect on
the relative risk of breast cancer in ever- vs never-smokers (Tables
3 and 4). In addition, possible confounding by race, education,
family history of breast cancer, age at menarche, height, weight,
body mass index, breastfeeding and use of hormonal preparations
was examined by adjustment for each factor in turn, but none
materially altered the estimates of relative risk (Table 3). Since
the relative risk estimates for breast cancer in relation to both alco-
hol and tobacco consumption did not appear to differ substantially
according to any of these factors, there is no strong evidence for
interaction between either of these exposures and the 15 factors
examined (Figure 4).
There was no significant difference in the extent of tumour
spread according to either alcohol or tobacco consumption,
suggesting that there is little differential detection of breast cancer
or effect on tumour growth by these exposures.
Combining results from different studies
Combining results across many studies has the advantage of yield-
ing estimates of the relative risk that are not subject to as much
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Table 3 Effect of additional adjustment for various factors on the relative risk of breast cancer associated with alcohol and
tobacco consumption
Relative risk (SE) of breast cancer in
Per cent increase (SE) in the relative risk of ever-smokers, compared to never-smokers
breast cancer per 10 g per day alcohol intake for women who reported drinking no alcohol
After stratification for study, age, parity, age at 7.1% (0.8%) 1.03 (0.02)
first birth and, for analyses concerning
alcohol, tobacco consumption
After additional stratification for:
race 7.2% (0.8%) 1.03 (0.02)
education 7.3% (0.8%) 1.04 (0.03)
mother or sister with breast cancer 7.2% (0.8%) 1.02 (0.03)
age at menarche 7.4% (0.8%) 1.04 (0.03)
height 7.5% (0.8%) 1.02 (0.03)
weight 7.2% (0.8%) 1.04 (0.03)
body mass index 6.9% (0.8%) 1.04 (0.03)
breastfeeding 6.9% (0.8%) 1.02 (0.02)
ever use of hormonal contraceptives 6.6% (0.8%) 1.02 (0.03)
ever use of hormone replacement therapy 7.3% (0.8%) 1.02 (0.03)
type of and age at menopause 7.2% (0.8%) 1.06 (0.03)
Table 4 Relative risk of breast cancer in ever vs never smokers,
according to menopausal status, in women who reported drinking no
alcohol. Relative risks are stratified by study, age, parity and age at first birth
Menopausal status Relative risk (SE)
Premenopausal 1.07 (0.05)
Natural menopause
before age 45 years 1.11 (0.15)
at age 45 – 49 years 0.98 (0.08)
at age 550 years 1.12 (0.06)
Bilateral oophorectomy
before age 45 years 0.78 (0.16)
at age 545 years 0.82 (0.15)
Hysterectomy before menopause 1.08 (0.09)
w26 for heterogeneity=7.5; P=0.9
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Figure 4 Relative risk of breast cancer in relation to alcohol and tobacco consumption in various subgroups of women.
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random fluctuation as that found in any individual study. The
studies that contributed to these findings were of different designs
and included women with a wide range of alcohol and tobacco
consumption and of other personal characteristics. Nevertheless,
the relationships between breast cancer and alcohol and tobacco
were seen consistently across studies and study designs, and for
women of different ages, different childbearing histories, and for
women who differed according to various other personal character-
istics. The results were not unduly influenced by any particular
study or groups of studies.
Because of the strong association between alcohol and tobacco
consumption, the main analyses were restricted to data from the
53 studies in which information on both exposures had been
collected in the same women. Results from the only study52 that
had provided individual data on alcohol, but not tobacco, did
not differ significantly from the overall findings for breast cancer
and alcohol. The remaining 11 studies53 – 63 that provided indivi-
dual data on tobacco, but not on alcohol, could not contribute
directly to this review, since it was not possible to take into
account for the important confounding effect of alcohol. None
of the publications from these 11 studies has, however, claimed
that smoking affected the risk of breast cancer.
As far as can be ascertained, over 80% of the worldwide epide-
miological data that have been assembled on the relationship
between breast cancer and alcohol and tobacco consumption were
contributed to this collaboration. Another 20 studies were identi-
fied with relevant data that together included about 12 000
women with breast cancer (see Appendix II (www.bjcancer.com)),
but because results were presented in a different way in each study,
it is difficult to combine the published data directly. Nevertheless,
out of the six largest studies all but one (reference number 66, in
Appendix II (www.bjcancer.com)) reported a statistically significant
increased risk of breast cancer with increasing intake of alcohol.
Each of these six studies included at least 500 women with breast
cancer and altogether they comprised most of the information that
had not been contributed in this collaboration. The remaining 14
studies were comparatively small and none of their published
results on alcohol differed substantially from those reported here.
Therefore the findings on alcohol and breast cancer from studies
not included here do not appear to differ materially from these
results.
Only one of the 20 studies that had not contributed to this
collaboration claimed that smoking is associated with an increased
risk breast cancer (reference number 81, in Appendix II
(www.bjcancer.com)). None of these studies has, however,
published results on the risk of breast cancer in relation to smok-
ing, restricted to women who never drank alcohol.
Limitations of these findings
Overall, the relative risk of breast cancer appeared to increase by
7.1% (95% CI 5.5 – 8.7%) for each additional 10 g per day intake
of alcohol i.e. for each extra unit/drink of alcohol consumed on a
daily basis. Information on alcohol consumption was, however,
usually self-reported, describing drinking habits at around the time
that the women were interviewed. No information on the pattern
of intake, including the type of alcohol consumed and the duration
of intake, was collected for this collaboration. There is no strong
evidence here to suggest biased reporting of alcohol consumption
in case-control studies, since there was no significant difference
in results between case – control and cohort studies (increases of
7.4% and 5.0% per 10 g per day, respectively; w21 for heterogene-
ity=1.5, P=0.2). However, self-reported information on alcohol
consumption is known to underestimate true consumption.68
Systematic under-reporting of consumption by both cases and
controls would result in an overestimation of the relative risk of
breast cancer for a given level of alcohol consumption. By contrast,
random misclassification among both cases and controls would
have the opposite effect, resulting in an underestimation of the
relative risk. These two types of measurement error are inevitable,
but counter-acting, and it is not possible to estimate their overall
effect on the relative risks calculated here. Moreover, the shape
of the dose-response relationship could be changed if, for example,
heavy drinkers were more likely to under-report intake than
moderate drinkers. Taken together, these reporting errors imply
that some uncertainty remains about the true quantitative effect
of an intake of a fixed amount of alcohol on the risk of developing
breast cancer.
The true relationship between alcohol consumption and breast
cancer might, perhaps, be more curved than is suggested by the
shape of the relationship shown in Figure 1, because of misclassi-
fication of alcohol intake, as may also have occurred with cigarette
smoking and lung cancer.71 Any firm conclusion about the risk of
breast cancer at low levels of alcohol intake is, however, prohibited
by the likelihood of measurement errors, particularly the tendency
for underestimation of the amount drunk, and by the possibility
that non-drinkers may differ in some relevant, but unmeasured,
ways from those who sometimes drink alcohol. Hence, the possibi-
lity of a threshold dose of alcohol cannot be reliably assessed from
the data in Figure 1.
These results provide no direct evidence about possible mechan-
isms of carcinogenesis by alcohol on the breast. There is, however,
accumulating evidence that regular intakes of moderate amounts of
alcohol affect sex hormone levels. For example, the results of a
recently published small randomised trial of 51 postmenopausal
women suggested that sex hormone levels may be increased after
the consumption of 30 g per day alcohol for 8 weeks,72 levels of
consumption that are associated here with a clear excess risk of
breast cancer.
With respect to the consumption of tobacco, the main exposure
variable examined here was whether or not a woman had ever
smoked. No information was collected for this collaboration on
the amount smoked or on the age that smoking started or stopped,
nor has attention been given to the reported effects of environmen-
tal exposure to tobacco,35,49 as active smoking only has been
considered. Although some past smokers may have smoked rela-
tively infrequently, current smokers are likely to have had
substantial lifetime exposures to tobacco, particularly in countries
where lung cancer rates in women are high. Just over half the
ever-smokers included in these analyses were current smokers,
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women in developed countries, according to the number of alcoholic
drinks consumed each day (see Methods).
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and among them the risk of breast cancer was similar to that in
never-smokers (relative risk=0.99 (95% CI, 0.96 – 1.03)). The find-
ings from case – control studies could, in theory, be biased if
women with breast cancer stopped smoking when they first devel-
oped symptoms, or if there were differential reporting of smoking
by cases and controls. However, the results from cohort studies,
where exposure information was collected prospectively, suggest
no increase in the risk of breast cancer in ever-smokers or current
smokers compared to never-smokers (relative risk=1.00, 95% CI
0.93 – 1.07, for ever-smokers; and =0.94, 95% CI 0.84 – 1.05, for
current smokers).
Public health implications
If the pattern of breast cancer associated with increasing levels of
alcohol consumption estimated here is valid, then about 4% of
the breast cancers in women in developed countries may be attri-
butable to alcohol. The consumption of alcohol by most women in
developed countries is relatively low, with about two-thirds
consuming little or no alcohol each day. For women in developed
countries who regularly drink alcohol, the lifetime risk of breast
cancer is estimated to increase by about 0.7 per 100 women for
each extra unit or drink of alcohol consumed on a daily basis.
For example, the cumulative incidence of breast cancer by age 80
years is estimated to increase from 8.8 per 100 women who drink
no alcohol to 10.1 or 100 who consume two alcoholic drinks daily
and to 11.6 per 100 who consume four drinks daily. This excess
risk should be considered in the context of the beneficial effects
of alcohol, in moderation, on cardiovascular disease, and its harm-
ful effects on cirrhosis and on cancers of the mouth, larynx,
oesophagus and the liver.73,74
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APPENDIX I. – COLLABORATORS (in alphabetical order
of institution, study name, or location)
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S Koetsawang, D Rachawat; Breast Tumor Collaborative Study, Johns
Hopkins University, MD, USA: A Morabia, L Schuman, W Stewart, M
Szklo; University of Queensland, Brisbane, Australia: C Bain, F Schofield,
V Siskind; British Columbia Cancer Agency, BC, Canada: P Band, AJ Cold-
man, RP Gallagher, TG Hislop, P Yang; Cancer Research Center, University
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Registries Epidemiology Research Group, Canada: J Hu, KC Johnson, Y
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for Disease Control & Prevention, GA, USA: N Lee, P Marchbanks, HW
Ory, HB Peterson, HG Wilson, PA Wingo; Central Institute of Cancer
Research, Berlin, Germany: K Ebeling, D Kunde, P Nishan; Centre for
Genetic Epidemiology, University of Melbourne, Melbourne, Australia: JL
Hopper; Channing Laboratory, Brigham and Women’s Hospital, Harvard
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M Gerber, S Richardson, C Segala; Nairobi Centre for Research in Repro-
duction, Nairobi, Kenya: D Gatei, P Kenya, A Kungu, JG Mati; National
Cancer Institute, MD, USA: LA Brinton, R Hoover, C Schairer; National
Institute of Child Health & Human Development, MD, USA: R Spirtas;
National University of Singapore, Singapore: HP Lee; The Netherlands Cancer
Institute, Amsterdam, The Netherlands: MA Rookus, FE van Leeuwen for
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